Anne Wagner
PhD, psychologist, and clinician/researcher at Remedy Institute / Toronto Metropolitan University
Data updated
Research Footprint
Anne Wagner appears in 8 tracked papers (2019–2024), most studied alongside MDMA and Psilocybin, across Depressive Disorders, PTSD and Anxiety Disorders.
Most-cited paper: Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation (102 citations).
Frequent co-authors: Michael Mithoefer, Candice Monson and Ann Mithoefer.
Background & Research
Anne C. Wagner is a psychologist and researcher whose work has focused on trauma, PTSD, couples therapy, and the use of MDMA-assisted psychotherapy. She has coauthored multiple papers on MDMA-facilitated cognitive-behavioral conjoint therapy and on mechanistic questions in psychedelic treatment, including experiential avoidance as a potential pathway of change. Her recent affiliations identify her with Remedy and Toronto Metropolitan University.
Key Impact
Anne C. Wagner is a notable psychedelics-and-PTSD researcher whose work bridges MDMA-assisted psychotherapy, couples therapy, and mechanism-focused studies relevant to psychedelic medicine.
Collaboration Network
19 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Anne Wagner is associated with.